Constitutive expression of glucagon-like peptide 1 for gene therapy of type 2 diabetes

被引：0
|
作者：
Parsons, GB
Yu, D
Souza, DW
Wu, H
Wadsworth, S
Gregory, R
Armentano, D
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A146 / A146
页数：1
相关论文
共 50 条
  • [21] New therapies for type 2 diabetes based on glucagon-like peptide 1
    Salehi, M
    D'Alessio, DA
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2006, 73 (04) : 382 - 389
  • [22] Glucagon-like peptide-1 agonists in the treatment of type 2 diabetes
    Edwards, C. M. B.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (04) : 198 - 201
  • [23] Glucagon-like peptide-1 in type 2 diabetes:: the β-cell and beyond
    Nauck, Michael A.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 2 - 13
  • [24] Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients
    ten Kulve, Jennifer S.
    van Bloemendaal, Liselotte
    Balesar, Rawien
    IJzerman, Richard G.
    Swaab, Dick F.
    Diamant, Michaela
    la Fleur, Susanne E.
    Alkemade, Anneke
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (05): : 2122 - 2129
  • [25] Glucagon-like peptide-1 and glucagon-like peptide-2
    Baggio, LL
    Drucker, DJ
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (04) : 531 - 554
  • [26] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [27] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
  • [28] Expression of glucagon-like peptide 1 receptor in a murine C cell line: Regulation of calcitonin gene by glucagon-like peptide 1
    Lamari, Y
    Boissard, C
    Moukhtar, MS
    Jullienne, A
    Rosselin, G
    Garel, JM
    FEBS LETTERS, 1996, 393 (2-3) : 248 - 252
  • [29] Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
    Nolen-Doerr, Eric
    Stockman, Mary-Catherine
    Rizo, Ivania
    CURRENT OBESITY REPORTS, 2019, 8 (03) : 284 - 291
  • [30] Mechanism of Glucagon-Like Peptide 1 Improvements in Type 2 Diabetes Mellitus and Obesity
    Eric Nolen-Doerr
    Mary-Catherine Stockman
    Ivania Rizo
    Current Obesity Reports, 2019, 8 : 284 - 291
12345